HomeReducing Adverse Drug Effects
Information & Quality Healthcare (IQH), the Quality Improvement Organization for Mississippi, is concentrating on individual-centered care that provides the right care for each person at the right time. In the Adverse Drug Events (ADEs) project, IQH is working to improve drug safety practices, reduce medication-related harm and develop innovative care standards for treating high-risk patients. Many adverse events are due to drug-to-drug interactions and medication errors, making adverse drug events a major source of potentially preventable patient harm.
IQH will support community-based teams to implement clinical pharmacy services. Clinical pharmacy services promotes the appropriate selection, utilization, and monitoring of medications to optimize individual therapeutic outcomes. These services are provided by a multidisciplinary health care team through individualized patient assessment and management. Clinical pharmacy services are best provided by a pharmacist or by another health care professional in collaboration with a pharmacist.
IQH will implement local collaborative teams of clinics, hospitals, pharmacies and nursing homes to participate in national collaborative learning sessions and participate in the Health Resources and Services Administration (HRSA), and Patient Safety and Clinical Pharmacy Services Collaborative (PSPC).
Goals for this project include:
- Reduction of adverse drug events and potential adverse drug events (pADEs) in the specific population of focus.
- Reduce ER visits, hospitalizations and hospital readmissions related to ADEs and pADEs.
- Reduce the number of patients on antipsychotics and potentially inappropriate medications.
- Monitor patients on warfarin to ensure lab tests are done timely and within acceptable range.
- Monitor patients with diabetes to ensure A1C values are within the controlled range.
 |
